Renal Cancer - Results from #5580

Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib August 15, 2016

Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development August 12, 2016

Clinicopathological and prognostic significance of survivin expression in renal cancer patients: a meta-analysis August 12, 2016

Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-labeled Pembrolizumab August 10, 2016

The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti-PD-1 Response in Patients with Renal Cell Carcinoma August 10, 2016

Predictive Immunohistochemical Markers Related to Drug Selection for Patients Treated with Sunitinib or Sorafenib for Metastatic Renal Cell Cancer August 10, 2016

Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients August 9, 2016

Immunotherapy of advanced renal cell carcinoma: Current and future therapies August 9, 2016

Second-line treatment for metastatic clear cell renal cell cancer: experts' consensus algorithms August 9, 2016

First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium August 8, 2016

Decreased TCL6 expression is associated with poor prognosis in patients with clear cell renal cell carcinoma August 8, 2016

Medical treatment of renal cancer: new horizons August 7, 2016

Renal fossa recurrence following nephrectomy for renal cell carcinoma: prognostic features and oncologic outcomes August 7, 2016

A tumor profile in Edwards syndrome (trisomy 18) August 5, 2016

Metastasis therapies for renal cancer August 4, 2016

Role of IL-2 in cancer immunotherapy August 4, 2016

[Cancer genetic screening for patient with multiple renal tumors: What is the current practice for what results?] August 3, 2016

Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Practical Clinical Implications of Pharmacologic Features August 2, 2016

Surveillance following surgery for nonmetastatic renal cell carcinoma August 1, 2016

Molecular profiling of renal cell carcinoma: building a bridge toward clinical impact August 1, 2016

Page 280 of 456